pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-433 |
Genomic Coordinates | chr14: 100881886 - 100881978 |
Synonyms | MIRN433, hsa-mir-433, miRNA433, MIR433 |
Description | Homo sapiens miR-433 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-433-3p | ||||||||||||
Sequence | 64| AUCAUGAUGGGCUCCUCGGUGU |85 | ||||||||||||
Evidence | Experimental | ||||||||||||
Experiments | Cloned | DRVs in miRNA |
|
||||||||||
SNPs in miRNA |
|
||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | STARD7 | ||||||||||||||||||||
Synonyms | GTT1 | ||||||||||||||||||||
Description | StAR related lipid transfer domain containing 7 | ||||||||||||||||||||
Transcript | NM_020151 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on STARD7 | |||||||||||||||||||||
3'UTR of STARD7 (miRNA target sites are highlighted) |
>STARD7|NM_020151|3'UTR 1 CAGGCTTTGGGATAAGAAGGGACAAGGTGCTTCTAGCCCTGTCTCAGTCCGTTATCACTCTGCTGTAGAAGGGGGACATG 81 CCACATGTATTAGAAGGCATCTGCTGTAACTTCCAGTGCAAGATAATTCAATAACTGATGTCCCATTTCATTCAGAGCCC 161 TTATTGCTCTTATCAAAACAGAAGAAGGCTACATTTGTGGGAGTGTTGTCATATTCTCAGGCCAACTGTTTTGAAATTCG 241 GTATCTCACTGAGCTAATCTGGAACAAACCTCTCACCTCAGGCCAGAAGGGGATGACCTCCATTTGCTTCTCTGAGTAGT 321 TTCCTCTGCTGACATTCCAAATCCCACCATCGATTGTGCAGCGCTTTGGATTTCCTTCAGTTCTCCAGGTCCACCTGGAA 401 AGTATAGTTGGCCAGTTGAGTCTCTCAAATGAGGGGCTACTGGGAGTGCTCTTGGTAACAATCATGATGTGAATGGGTGT 481 GAACGATACTTGGCTATGTTAAGTGCCTTGTCCGCACCTTGCTTTTATCTCTAGAGACATGAAGTTATTATTAATTTTTT 561 TTTTTTTTAAGTAGAGATGGAGTTTCACTCTGTTTCCCAGGCTGGTCTTGAACTCCTGGGCCATGCCTGGCCAGGGACAT 641 GAATTTGTACAAAGAAATTTCCCTCCCTGCCTGCACAATATCACCCATTGACTCACCTTATCCAAAGCAAGTTTCCTGTG 721 AATCGGCCAGTTCTTCTATATTCATTGGATCATTGCCTCCTTCCTAACCTTCCCCATTTACCAAGAACACTGGGAGACTA 801 ATCCTTTTAGATAGTAGCTTTTTGATGCTCAAAACATCACATTTAAATTTAGTTTAAAAATTTTTTAACTTTTGTGTCAA 881 ATAGGAGTTGAGGAATTGAGCAGGATTCTACCCTAGTCCGATTGTATAGAAAACACCATTTTGATTCAGGTATTATTTTT 961 CATATTTCAGGTTTGACTTGTTCTTTTCAGAAGGCTAAAGTCAGAGGAATGGGGGCTGGGCCACTCCCTTGGAGCTCTCA 1041 GATCTACAGACAAGCTGTGTGAATGCATAGATGTAATCTTGTCTCAAATACTAATACAGTGGAGATTTGGTTTATGTTAC 1121 CATTAAGTTCCTCTAAAAAGTTTTTCTTCCTCTCTTCAGAGCCAAAATAAAAGTGAACTACACTGTTCAGATAAGGTCAC 1201 AATCTGATGCTGTCAGTTTGACCGAGCTGGTTTTGCTTATGGTCATGCTGCAATTTGTTAGAATAATAGGGATCAAGTTT 1281 TAAATCCTCCTCCTTCCCTTTTTTCTGGAGTCTTGAGGGCCAGAGTTTTTGTTTTTGTTTTTGTTTTTGTTTTCCTGCTT 1361 GCTACTGTTTTGTGGTGTTGAAAAGTGGTTTAAACCTGAGACTAACTTAAACACTTCCTTGACCTTCTTGTTGCCTGTTC 1441 ATTTTTGTGCCAAGGAAGTAGCTGCCCCAGTGTATGTCTTGCCTTCTCCGCGTCATTGTTGGAAGAGGAGAGATGCATCG 1521 AGCAGTCCCAGCTGCTTTTCATTTATTACTTCTTCTTTCCAGGACCTGACAGAAGTCAGGGAAGAGTCCCTGGGTTATGT 1601 CCAAACTTAGCACCTGCAATTGTTGGGATGTGGATGGATGTGTGCATAAGAGAGAGAGAGAATATGTGTGTGTGTGTGTG 1681 CGTCTGCGAGCGCACACACATGCACAAGTGCGAAGGAGTTGCGGTTGCTCCATGTTCTGACTTAGGGCAATTTGATTCTG 1761 CACTTGGGGTCTGTCTGTACAGTTACTCATGTCATTGTAATGATTTCACTCCTAACTGTGACATTTTTATCAAATGTGTG 1841 AATAAATACATAAAGATTGGTACAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Hela |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1048187. RNA binding protein: AGO2. Condition:Hela_AGO2_CLIP_control
... - Xue Y; Ouyang K; Huang J; Zhou Y; Ouyang H; et al., 2013, Cell. |
Article |
- Xue Y; Ouyang K; Huang J; Zhou Y; Ouyang H; et al. - Cell, 2013
The induction of pluripotency or trans-differentiation of one cell type to another can be accomplished with cell-lineage-specific transcription factors. Here, we report that repression of a single RNA binding polypyrimidine-tract-binding (PTB) protein, which occurs during normal brain development via the action of miR-124, is sufficient to induce trans-differentiation of fibroblasts into functional neurons. Besides its traditional role in regulated splicing, we show that PTB has a previously undocumented function in the regulation of microRNA functions, suppressing or enhancing microRNA targeting by competitive binding on target mRNA or altering local RNA secondary structure. A key event during neuronal induction is the relief of PTB-mediated blockage of microRNA action on multiple components of the REST complex, thereby derepressing a large array of neuronal genes, including miR-124 and multiple neuronal-specific transcription factors, in nonneuronal cells. This converts a negative feedback loop to a positive one to elicit cellular reprogramming to the neuronal lineage.
LinkOut: [PMID: 23313552]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1048187 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | Hela / Hela_AGO2_CLIP_control |
Location of target site | ENST00000337288.5 | 3UTR | AAGUAUAGUUGGCCAGUUGAGUCUCUCAAAUGAGGGGCUACUGGGAGUGCUCUUGGUAACAAUCAUGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23313552 / GSE42701 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000337288.5 | 3UTR | CUACUGGGAGUGCUCUUGGUAACAAUCAUGAUGUGAAUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
75 hsa-miR-433-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT001201 | GRB2 | growth factor receptor bound protein 2 | 3 | 1 | ||||||||
MIRT001741 | FGF20 | fibroblast growth factor 20 | 3 | 1 | ||||||||
MIRT007225 | RUNX2 | runt related transcription factor 2 | 1 | 1 | ||||||||
MIRT007361 | CFTR | cystic fibrosis transmembrane conductance regulator | 1 | 1 | ||||||||
MIRT016630 | HDAC6 | histone deacetylase 6 | 1 | 1 | ||||||||
MIRT053561 | KRAS | KRAS proto-oncogene, GTPase | 3 | 1 | ||||||||
MIRT082022 | COX6B1 | cytochrome c oxidase subunit 6B1 | 2 | 4 | ||||||||
MIRT086929 | CREB1 | cAMP responsive element binding protein 1 | 3 | 1 | ||||||||
MIRT096407 | C5ORF22 | chromosome 5 open reading frame 22 | 2 | 2 | ||||||||
MIRT135569 | SPRYD4 | SPRY domain containing 4 | 2 | 2 | ||||||||
MIRT143520 | CHD9 | chromodomain helicase DNA binding protein 9 | 2 | 2 | ||||||||
MIRT167706 | HIVEP1 | human immunodeficiency virus type I enhancer binding protein 1 | 2 | 8 | ||||||||
MIRT207568 | STARD7 | StAR related lipid transfer domain containing 7 | 2 | 4 | ||||||||
MIRT252052 | WDR45B | WD repeat domain 45B | 2 | 2 | ||||||||
MIRT327787 | YIPF6 | Yip1 domain family member 6 | 2 | 2 | ||||||||
MIRT406144 | SERBP1 | SERPINE1 mRNA binding protein 1 | 2 | 2 | ||||||||
MIRT437355 | GBP2 | guanylate binding protein 2 | 3 | 1 | ||||||||
MIRT438242 | TYMS | thymidylate synthetase | 3 | 1 | ||||||||
MIRT438553 | AZIN1 | antizyme inhibitor 1 | 4 | 1 | ||||||||
MIRT444186 | SCAMP1 | secretory carrier membrane protein 1 | 2 | 2 | ||||||||
MIRT477737 | EDN1 | endothelin 1 | 2 | 2 | ||||||||
MIRT483052 | SMU1 | DNA replication regulator and spliceosomal factor | 2 | 2 | ||||||||
MIRT485778 | ATXN1 | ataxin 1 | 2 | 2 | ||||||||
MIRT498142 | FKBP1C | FK506 binding protein 1C | 2 | 4 | ||||||||
MIRT499050 | SSC5D | scavenger receptor cysteine rich family member with 5 domains | 2 | 8 | ||||||||
MIRT501959 | MAPK8 | mitogen-activated protein kinase 8 | 2 | 2 | ||||||||
MIRT503281 | TMEM229B | transmembrane protein 229B | 2 | 4 | ||||||||
MIRT503597 | ZNF780A | zinc finger protein 780A | 2 | 2 | ||||||||
MIRT504577 | UGT2B4 | UDP glucuronosyltransferase family 2 member B4 | 2 | 4 | ||||||||
MIRT506727 | LONRF2 | LON peptidase N-terminal domain and ring finger 2 | 2 | 2 | ||||||||
MIRT523130 | HSP90B1 | heat shock protein 90 beta family member 1 | 2 | 4 | ||||||||
MIRT531338 | TGIF2LX | TGFB induced factor homeobox 2 like, X-linked | 2 | 2 | ||||||||
MIRT534928 | PTPLAD1 | 3-hydroxyacyl-CoA dehydratase 3 | 1 | 1 | ||||||||
MIRT536233 | LRIG3 | leucine rich repeats and immunoglobulin like domains 3 | 2 | 2 | ||||||||
MIRT537092 | GPR135 | G protein-coupled receptor 135 | 2 | 2 | ||||||||
MIRT548286 | FAM3C | family with sequence similarity 3 member C | 2 | 4 | ||||||||
MIRT549143 | BRWD1 | bromodomain and WD repeat domain containing 1 | 2 | 2 | ||||||||
MIRT556354 | MAFK | MAF bZIP transcription factor K | 2 | 2 | ||||||||
MIRT557839 | FKBP1A | FK506 binding protein 1A | 2 | 2 | ||||||||
MIRT564080 | NSA2 | NSA2, ribosome biogenesis homolog | 2 | 2 | ||||||||
MIRT566382 | PLEKHA1 | pleckstrin homology domain containing A1 | 2 | 2 | ||||||||
MIRT573110 | ERBB2IP | erbb2 interacting protein | 2 | 2 | ||||||||
MIRT574403 | TFAP2A | transcription factor AP-2 alpha | 2 | 2 | ||||||||
MIRT576063 | Poteg | POTE ankyrin domain family, member G | 2 | 2 | ||||||||
MIRT619449 | TCF20 | transcription factor 20 | 2 | 2 | ||||||||
MIRT632928 | FGF9 | fibroblast growth factor 9 | 2 | 2 | ||||||||
MIRT633216 | ZNF584 | zinc finger protein 584 | 2 | 2 | ||||||||
MIRT633654 | SLC28A1 | solute carrier family 28 member 1 | 2 | 2 | ||||||||
MIRT637198 | KLHL4 | kelch like family member 4 | 2 | 2 | ||||||||
MIRT646480 | SPATS2L | spermatogenesis associated serine rich 2 like | 2 | 2 | ||||||||
MIRT648314 | SCNN1G | sodium channel epithelial 1 gamma subunit | 2 | 2 | ||||||||
MIRT648631 | LEMD2 | LEM domain containing 2 | 2 | 2 | ||||||||
MIRT655902 | NEK9 | NIMA related kinase 9 | 2 | 2 | ||||||||
MIRT667805 | ITIH5 | inter-alpha-trypsin inhibitor heavy chain family member 5 | 2 | 2 | ||||||||
MIRT675464 | NUBPL | nucleotide binding protein like | 2 | 2 | ||||||||
MIRT675974 | FAM126B | family with sequence similarity 126 member B | 2 | 2 | ||||||||
MIRT676145 | ALDOA | aldolase, fructose-bisphosphate A | 2 | 2 | ||||||||
MIRT676895 | GABPB1 | GA binding protein transcription factor beta subunit 1 | 2 | 2 | ||||||||
MIRT677459 | PDLIM3 | PDZ and LIM domain 3 | 2 | 2 | ||||||||
MIRT677533 | TM4SF5 | transmembrane 4 L six family member 5 | 2 | 2 | ||||||||
MIRT677641 | HAUS2 | HAUS augmin like complex subunit 2 | 2 | 2 | ||||||||
MIRT678806 | HRH4 | histamine receptor H4 | 2 | 2 | ||||||||
MIRT679693 | SLC1A5 | solute carrier family 1 member 5 | 2 | 4 | ||||||||
MIRT679707 | RPL24 | ribosomal protein L24 | 2 | 2 | ||||||||
MIRT698822 | STK38 | serine/threonine kinase 38 | 2 | 2 | ||||||||
MIRT701796 | MRPS25 | mitochondrial ribosomal protein S25 | 2 | 2 | ||||||||
MIRT702220 | LONRF3 | LON peptidase N-terminal domain and ring finger 3 | 2 | 2 | ||||||||
MIRT706095 | ENTPD4 | ectonucleoside triphosphate diphosphohydrolase 4 | 2 | 2 | ||||||||
MIRT706502 | MTMR9 | myotubularin related protein 9 | 2 | 2 | ||||||||
MIRT709780 | NINJ1 | ninjurin 1 | 2 | 2 | ||||||||
MIRT713859 | MBNL1 | muscleblind like splicing regulator 1 | 2 | 2 | ||||||||
MIRT715807 | BBS2 | Bardet-Biedl syndrome 2 | 2 | 2 | ||||||||
MIRT724229 | DGKE | diacylglycerol kinase epsilon | 2 | 2 | ||||||||
MIRT731338 | MET | MET proto-oncogene, receptor tyrosine kinase | 1 | 1 | ||||||||
MIRT731849 | HIF1A | hypoxia inducible factor 1 alpha subunit | 3 | 1 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|